Skip to main content

Hercules Capital, Inc.

corporate_fare Company Profile

Hercules Capital, Inc.

HTGC·NYSE·Finance·CIK 0001280784

Hercules Capital, Inc. is a specialty finance company that provides senior secured loans to high-growth, innovative companies backed by venture capital and institutions. The company focuses on technology and life sciences industries. Within technology, investments are made in sub-sectors such as computer software and hardware, networking systems, semiconductors, semiconductor capital equipment, information technology infrastructure or services, consumer and business services, telecommunications, telecommunications equipment, and media. In the life sciences sub-sector, the focus is on medical devices, bio-pharmaceutical, drug discovery and development, drug delivery, health care services, and information systems companies. The primary business objectives are to increase net income, net investment income, and net asset value (NAV) by investing in primarily Structured Debt or senior secured debt instruments of these technology-related companies at attractive yields. Structured Debt refers to debt investments that include an equity, warrant, option, or other right to purchase or convert into common or preferred equity. The company aims to maximize portfolio total return through current income from debt investments and capital appreciation from warrant and equity investments. Hercules Capital, Inc., its subsidiaries, or affiliates may also manage other funds that invest in debt, equity, or provide financing or services to companies across various industries, earning management or other fees. They may also invest in the equity of these funds alongside third parties, seeking returns and/or future incentive allocations.

Hercules Capital, Inc. (NYSE:HTGC) is a publicly traded company in the Finance sector. Wiseek has independently scored 21 items for HTGC at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Hercules Capital Pre-Announces Strong Q4 2025 Results with Significant Asset Quality Improvement

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
$339.74M
Diluted EPS
$1.85
Op. Cash Flow
-$425.8M
Free Cash Flow
-$425.89M
Cash & Equivalents
$56.87M
Total Debt
$2.29B
Debt / Equity
1.03×
Shares Outstanding
182.69M sh
Source: 10-K · filed 2026-02-12 · accession 0001280784-26-000009
$17 +0.26% today
52-week range · as of 2026-07-30 $13.7 – $19.67
Market cap
$3.13B
Volume
1.2M (0.9× avg)
3-mo avg 1.4M
Live data · 2026-10-05 05:56 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed HTGC - Filings & News (Page 2)

HTGC
Feb 03, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $18.30
Real-time Price: $17.00 info
Change: -$1.30 (-7%) info
Market Cap: $3.133B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets